Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by somweyungguyon Apr 21, 2016 10:24am
159 Views
Post# 24793401

Ooops "BaggedBailingBunny" is promoting toxic material again

Ooops "BaggedBailingBunny" is promoting toxic material againFirst it was UBS, and then it was SELL Spectral as "RetailRube"

T.GEN just raised at a dime...here's how they did it;

Financial hardship exemption

As the aggregate number of common shares issuable pursuant to the offering exceeds 25 per cent of the currently issued and outstanding common shares of the company, the offering may result in a new control person of the company and the discount on pricing is above the allowable limits, GeneNews would ordinarily be required to obtain shareholder approval pursuant to the applicable policies of the TSX, which are Section 607(g)(i) and Section 604(1)(i) and Section 607(e), respectively, of the TSX company manual. However, the company has applied to the TSX, pursuant to the provisions of Section 604(e) of the manual, for a financial hardship exemption from the requirement to obtain shareholder approval, on the basis that the company is in serious financial difficulty and the offering is designed to improve the company's financial situation. The application was made upon the recommendation of the board, free from any interest in the transaction and unrelated to the parties involved in the transaction, and was based on their determination that the transaction is reasonable for GeneNews in the circumstances.

<< Previous
Bullboard Posts
Next >>